This study aims to retrospectively collect data from patients with meningioma pathologically diagnosed between January 2019 and June 2025.
Conditions
Interventions
Sponsors
Yuebei People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. No restriction on sex; age >= 18 years. 2. Pathological diagnosis of meningioma in accordance with the 2016 WHO criteria, including WHO grade and subtype. 3. Preoperative cranial MRI examinations (both plain and contrast-enhanced scans) performed within 2 weeks prior to surgery. 4. Complete clinical data and imaging quality meet diagnostic requirements
Exclusion criteria
Exclusion criteria: 1.Patients who received radiotherapy, chemotherapy, or other treatments prior to MRI examination; 2.Lesions too small to be adequately visualized on MRI (<3 slices); 3.Incomplete clinical or surgical data, or poor image quality affecting diagnostic evaluation; 4. Postoperative pathological diagnosis is unclear; 5. Patients lacking postoperative follow-up information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patiens Prognostic status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative recovery time; | — |
Countries
China
Contacts
Public ContactXiang Liu
Yuebei People’s Hospital
Outcome results
None listed